Ayala Pharmaceuticals Inc (ADXS)
0.54
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Ayala Pharmaceuticals Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | -34.51M |
| September 30, 2022 | -34.13M |
| June 30, 2022 | -34.17M |
| March 31, 2022 | -38.69M |
| December 31, 2021 | -38.36M |
| September 30, 2021 | -37.54M |
| June 30, 2021 | -37.03M |
| Date | Value |
|---|---|
| March 31, 2021 | -30.80M |
| December 31, 2020 | -27.54M |
| September 30, 2020 | -24.26M |
| June 30, 2020 | -20.55M |
| March 31, 2020 | -17.78M |
| December 31, 2019 | -14.95M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-38.69M
Minimum
Mar 2022
-14.95M
Maximum
Dec 2019
-30.02M
Average
-34.13M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Taro Pharmaceutical Industries Ltd | 142.87M |
| InspireMD Inc | -16.38M |
| BiomX Inc | -21.29M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -18.47M |